NXL Nexalin Technology, Inc.
4.320USD-4.00%Mkt Cap: 3.70M $P/E: —1d ago
Nexalin Technology, Inc., a medical device company, designs and develops neurostimulation products for the treatment of mental health epidemic in the United States and China. The company offers Generation 1, an easy-to-a…
Industry Peers
Medical DevicesKey Statistics
Company
Market Cap3.70M USD
Enterprise Value2.30M USD
Revenue (TTM)217.16K USD
Gross Profit240.27K USD
Net Income (TTM)-8.22M USD
Revenue/Share0.34 USD
Last Price4.320 USD
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees8
CountryUS
SectorHealthcare
IndustryMedical Devices
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-0.60
PEG—
EV/EBITDA-0.25
EV/Revenue10.59
P/S17.73
P/B2.17
EPS (TTM)-11.98
EPS (Forward)-7.55
52W Range
4.1000% of range60.00
52W High60.00 USD
52W Low4.100 USD
Profitability
Gross Margin79.65%
Oper. Margin-18479.69%
EBITDA Margin0.00%
Profit Margin-2725.76%
ROE-219.38%
ROA-177.38%
Growth
Revenue Growth-82.80%
Earnings Growth—
Cash Flow & Leverage
Operating CF-4.96M USD
CapEx (TTM)96.86K USD
FCF Margin-1166.64%
FCF Yield-68.55%
Net Debt-1.00M USD
Net Debt/EBITDA0.11
Balance Sheet
Debt/Equity—
Current Ratio1.25
Quick Ratio0.71
Book Value/Sh2.07 USD
Cash/Share1.37 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.00 USD
Div. Yield0.00%
5Y Avg Yield—
Payout Ratio—
Ex-Div Date—
Pay Date—
Splits
Last Split1:30
Split DateAug 31, 2026
Analyst Consensus
Rating2.0 (Buy)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)15.00 USD
Upside (mean)+247.2%
Target Range15.00 USD – 15.00 USD
# Analysts1
Ownership
Shares Out.855.51K
Float530.68K
Insiders24.58%
Institutions3.45%
Short Interest
Short Ratio0.9d
Short % Float1.55%
Short % Out.1.51%
Shares Short12.50K
Short (prev mo.)11.41K
Technical
SMA 507.638 (-43.4%)
SMA 20012.64 (-65.8%)
Beta4.11
S&P 52W Chg16.45%
Avg Vol (30d)2.11M
Avg Vol (10d)6.41M
Technical Indicators
RSI (14)38.7
MACD-0.8662
MACD Signal-1.0915
MACD Hist.+0.2253
BB Upper6.369 USD
BB Middle4.897 USD
BB Lower3.426 USD
BB Width60.10%
ATR (14)1.132 USD
Vol Ratio (20d)0.03x